| Combinatorial peptide libraries: mining for cell-binding peptides BP Gray, KC Brown Chemical reviews 114 (2), 1020-1081, 2014 | 272 | 2014 |
| Tunable cytotoxic aptamer–drug conjugates for the treatment of prostate cancer BP Gray, L Kelly, DP Ahrens, AP Barry, C Kratschmer, M Levy, ... Proceedings of the National Academy of Sciences 115 (18), 4761-4766, 2018 | 135 | 2018 |
| From phage display to nanoparticle delivery: functionalizing liposomes with multivalent peptides improves targeting to a cancer biomarker BP Gray, S Li, KC Brown Bioconjugate chemistry 24 (1), 85-96, 2013 | 105 | 2013 |
| Identification and characterization of a suite of tumor targeting peptides for non-small cell lung cancer MJ McGuire, BP Gray, S Li, D Cupka, LA Byers, L Wu, S Rezaie, YH Liu, ... Scientific reports 4, 4480, 2014 | 59 | 2014 |
| A liposomal drug platform overrides peptide ligand targeting to a cancer biomarker, irrespective of ligand affinity or density BP Gray, MJ McGuire, KC Brown PLoS One 8 (8), e72938, 2013 | 57 | 2013 |
| Synthesis and biological evaluation of a peptide–paclitaxel conjugate which targets the integrin αvβ6 S Li, BP Gray, MJ McGuire, KC Brown Bioorganic & medicinal chemistry 19 (18), 5480-5489, 2011 | 46 | 2011 |
| Phosphonium Ionic Liquids as Solvents for Nitration Reactions of Arenes BD Powell, GL Powell, PC Reeves Letters in Organic Chemistry 2, 550-553, 2005 | 26 | 2005 |
| Aptamer-programmable adeno-associated viral vectors as a novel platform for cell-specific gene transfer F Puzzo, C Zhang, BP Gray, F Zhang, BA Sullenger, MA Kay Molecular Therapy-Nucleic Acids 31, 383-397, 2023 | 21 | 2023 |
| An Aptamer for Broad Cancer Targeting and Therapy B Powell Gray, X Song, DS Hsu, C Kratschmer, M Levy, AP Barry, ... Cancers 12 (11), 3217, 2020 | 19 | 2020 |
| Aptamers as reversible sorting ligands for preparation of cells in their native state BP Gray, MD Requena, MD Nichols, BA Sullenger Cell Chemical Biology, 2019 | 18 | 2019 |
| An Aptamer That Rapidly Internalizes into Cancer Cells Utilizes the Transferrin Receptor Pathway X Song, H Yu, C Sullenger, BP Gray, A Yan, L Kelly, B Sullenger Cancers 15 (8), 2301, 2023 | 5 | 2023 |
| Rapid molecular imaging of active thrombi in vivo using aptamer-antidote probes BP Gray, L Kelly, KA Steen-Burrell, JM Layzer, RE Rempel, SM Nimjee, ... Molecular Therapy-Nucleic Acids 31, 440-451, 2023 | 4 | 2023 |
| Thrombus imaging aptamers and methods of using same BA Sullenger, KAC Steen-Burrell, BP Gray US Patent 10,660,973, 2020 | 4 | 2020 |
| MicroRNA let-7b enhances spinal cord nociceptive synaptic transmission and induces acute and persistent pain through neuronal and microglial signaling O Chen, C Jiang, T Berta, BP Gray, K Furutani, BA Sullenger, RR Ji Pain, 10.1097, 2022 | 3 | 2022 |
| Protocol for purification of cells in their native state using reversible aptamer-antidote pairs MD Requena, BP Gray, BA Sullenger STAR protocols 4 (3), 102348, 2023 | 1 | 2023 |
| Antidote-mediated reversal of extracellular aptamer staining B Sullenger, B Gray, M Nichols US Patent 11,634,772, 2023 | 1 | 2023 |
| 65. A novel aptamer targeting agent for prostate Cancer BP Gray, L Kelly, M Levy, BA Sullenger Molecular Therapy 23, S28-S29, 2015 | 1 | 2015 |
| 65. A Novel Aptamer Targeting Agent for Prostate Cancer BP Gray, L Kelly, M Levy, BA Sullenger Molecular Therapy 23, S28-S29, 2015 | 1 | 2015 |
| Nucleolin-targeting aptamers and methods of using the same BA Sullenger, M Goldstein, ED Pratico, M Kastan, B Gray US Patent App. 18/205,390, 2024 | | 2024 |
| Antidote-mediated reversal of extracellular aptamer staining B Sullenger, B Gray, M Nichols US Patent App. 18/128,949, 2024 | | 2024 |
Bruce SullengerDuke University
